CVS settles AirShield case
This article was originally published in The Tan Sheet
Executive Summary
CVS Pharmacy will pay nearly $2.8 million to settle FTC allegations it falsely advertised that its AirShield dietary supplement prevents colds, fights germs and boosts the immune system. FTC alleged the drugstore chain had no evidence to support the claims, according to a Sept. 8 FTC announcement. The allegations are similar to those FTC made against Airborne Health, Improvita Health Products and Rite Aid for similar supplements. Rite Aid paid $500,000 to settle allegations its Germ Defense ads misled consumers (1"The Tan Sheet" July 20, 2009). Airborne agreed to pay up to $30 million in consumer redress for alleged false ads (2"The Tan Sheet" Aug. 18, 2008). FTC is in litigation with Improvita